20/20 Biolabs, Inc.
AIDX· Nasdaq
AIDX20/20 Biolabs, Inc.
Who holds 20/20 Biolabs, Inc., from the managers’ Form 13F reports for the quarter ended Jun 30, 2026.
Form 13F covers managers with $100 million or more. Positions are as of the quarter end and filed up to 45 days later; the latest quarter fills in as reports land.
| Manager | Shares | Change | Value | Of portfolio | Filed |
|---|---|---|---|---|---|
| Cresset Asset Management, LLC | 240.1K | −9.2% | $132K | 0.1% | Aug 14, 2026 |
| Vanguard Fiduciary Trust Co | 52.1K | New | $28.6K | 0% | Aug 13, 2026 |
| Geode Capital Management, LLC | 49.1K | New | $27K | 0% | Aug 12, 2026 |
| Atlantic Union Bankshares Corp | 35.1K | New | $19.3K | 0.1% | Aug 11, 2026 |
| Vanguard Capital Management LLC | 24.5K | New | $13.5K | 0% | Aug 13, 2026 |
| Citadel Advisors LLC | 23.2K | +43.0% | $12.8K | 0% | Sep 2, 2026 |
| Bank of America Corp | 13K | New | $7.2K | 0% | Aug 14, 2026 |
| Susquehanna International Group, LLP | 10K | New | $5.5K | 0% | Aug 14, 2026 |
| McDonald Partners LLC | 2.8K | New | $1.5K | 0.1% | Jul 28, 2026 |
| Signaturefd, LLC | 767 | New | $422 | 0% | Jul 24, 2026 |
| Morgan Stanley | 283 | New | $156 | 0% | Aug 13, 2026 |
| Allworth Financial LP | 172 | +473.3% | $95 | 0% | Aug 11, 2026 |
| Toth Financial Advisory Corp | 100 | −36.3% | $55 | 0% | Jul 14, 2026 |
| HRT Financial LP | 89.3K | New | $49 | 0.1% | Aug 14, 2026 |
| UBS Group AG | 3 | −100.0% | $2 | 0% | Aug 13, 2026 |
